Canopy Growth (CGC) Analysts See $-0.09 EPS; Kelly Services – Class A (KELYA) Sellers …

Kelly Services Inc – Class A (NASDAQ:KELYA) had a decrease of 14.64% in short interest. KELYA’s SI was 432,000 shares in January as released by …

Kelly Services, Inc. (NASDAQ:KELYA) Logo

Kelly Services Inc – Class A (NASDAQ:KELYA) had a decrease of 14.64% in short interest. KELYA’s SI was 432,000 shares in January as released by FINRA. Its down 14.64% from 506,100 shares previously. With 110,900 avg volume, 4 days are for Kelly Services Inc – Class A (NASDAQ:KELYA)’s short sellers to cover KELYA’s short positions. The SI to Kelly Services Inc – Class A’s float is 1.39%. The stock decreased 1.96% or $0.45 during the last trading session, reaching $22.54. About 34,750 shares traded. Kelly Services, Inc. (NASDAQ:KELYA) has declined 27.82% since January 23, 2018 and is downtrending. It has underperformed by 27.82% the S&P500. Some Historical KELYA News: 08/05/2018 – Kelly Educational Staffing® Marks National Teacher Appreciation Day by Honoring Paul McDaniel as Florida Substitute Teacher o; 09/03/2018 – KELLY SERVICES INC – WITH GERALD ADOLPH’S ADDITION, KELLY SERVICES’ BOARD HAS 10 MEMBERS; 10/05/2018 – Kelly Services 1Q Rev $1.40B; 09/03/2018 Kelly Services® Elects New Board Member; 09/05/2018 – Kelly Services Access Event Scheduled By Northcoast Research; 09/03/2018 – Kelly Services Elect Gerald Adolph to Board, Which Now Numbers 10 Member; 09/03/2018 – KELLY SERVICES BOOSTS BOARD TO 10, APPOINTS GERALD ADOLPH; 08/05/2018 – Kelly Educational Staffing® Names Nicolae Boariu as National Substitute Teacher of the Year 2018; 10/05/2018 – Kelly Services 1Q Adj EPS 32c; 26/03/2018 – Kelly Services Closes Above 50-Day Moving Average: Technicals

Analysts expect Canopy Growth Corporation (NYSE:CGC) to report $-0.09 EPS on February, 13.They anticipate $0.02 EPS change or 18.18% from last quarter’s $-0.11 EPS. After having $-0.76 EPS previously, Canopy Growth Corporation’s analysts see -88.16% EPS growth. It closed at $43.66 lastly. It is down 117.84% since January 23, 2018 and is uptrending. It has outperformed by 117.84% the S&P500. Some Historical CGC News: 28/05/2018 DR. MARK WARE JOINS CANOPY GROWTH CORPORATION AS CHIEF MEDICAL OFFICER; 30/05/2018 – CANOPY GROWTH CORP – ALL KEY MEMBERS OF HIGHLANDS’S MANAGEMENT TEAM WILL CONTINUE TO LEAD ORGANIZATION AS PART OF CANOPY GROWTH; 30/05/2018 – CANOPY GROWTH ACQUIRES DADDY CANN LESOTHO; 31/05/2018 – CANOPY RIVERS – BOARD NOW INCLUDES TWO NOMINEES OF CANOPY GROWTH CORP AND THREE INDEPENDENT DIRECTORS; 28/05/2018 – MARK WARE JOINS CANOPY GROWTH AS CHIEF MEDICAL OFFICER; 30/05/2018 – Canopy Growth Corporation Announces Entry Into The African Market With Acquisition Of Daddy Cann Lesotho

Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company has market cap of $14.97 billion. The firm offers dried, oil, and softgel cannabis products. It currently has negative earnings. Canopy Growth Corporation also sells its products through online.

More notable recent Canopy Growth Corporation (NYSE:CGC) news were published by: Benzinga.com which released: “CIBC Initiates Coverage On Cannabis Stocks, Sees Bright Future Ahead (NYSE:CGC)(NASDAQ:CRON)(NYSE:APHA) – Benzinga” on January 18, 2019, also Fool.com with their article: “Recent Deals for Canopy Growth and Aurora Cannabis Show Why One of These Marijuana Stocks Is a Great Pick — and One Isn’t – Motley Fool” published on January 20, 2019, Fool.com published: “Should You Buy Canopy Growth in 2019? – The Motley Fool” on January 01, 2019. More interesting news about Canopy Growth Corporation (NYSE:CGC) were released by: Profitconfidential.com and their article: “Canopy Growth Corp (NYSE:CGC): Still a Top Marijuana Stock for 2019 – Profit Confidential” published on January 07, 2019 as well as Investorplace.com‘s news article titled: “Is CGC Stock All Hype or Opportunity? – Investorplace.com” with publication date: December 28, 2018.

More notable recent Kelly Services, Inc. (NASDAQ:KELYA) news were published by: Seekingalpha.com which released: “Kelly Services updates on acquisitions – Seeking Alpha” on January 08, 2019, also Prnewswire.com with their article: “Expanding the Power of Oneâ„¢ – Trustpoint.One Acquires Kelly Legal Managed Services – PRNewswire” published on January 14, 2019, Globenewswire.com published: “Kelly Services® Reports Third Quarter Earnings Nasdaq:KELYA – GlobeNewswire” on November 07, 2018. More interesting news about Kelly Services, Inc. (NASDAQ:KELYA) were released by: Nasdaq.com and their article: “Kelly Services, Inc. (KELYA) Ex-Dividend Date Scheduled for August 20, 2018 – Nasdaq” published on August 17, 2018 as well as Globenewswire.com‘s news article titled: “Kelly Services® Reports First Quarter 2018 Earnings Nasdaq:KELYA – GlobeNewswire” with publication date: May 10, 2018.

Kelly Services, Inc., together with its subsidiaries, provides workforce solutions to various industries worldwide. The company has market cap of $871.53 million. The firm operates through seven divisions: Americas Commercial; Americas Professional and Technical; Europe, Middle East and Africa Commercial; Europe, Middle East and Africa Professional and Technical; Asia Pacific Commercial; Asia Pacific Professional and Technical; and Outsourcing and Consulting Group. It has a 13.82 P/E ratio. It offers trained employees for data entry, clerical, and administrative support roles; staff for contact centers, technical support hotlines, and telemarketing units; instructional and non-instructional employees for schools; support staff for seminars, sales, and trade shows; assemblers, quality control inspectors, and technicians for electronic assembly; maintenance workers, material handlers, and assemblers for light industrial maintenance; and temporary-to-hire services, as well as direct-hire placement and vendor on-site management services.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

MedMen: Searching for value in a bull market for cannabis

… or Aurora Cannabis (NYSE:ACB) at $6.23 billion. The recently announced Aurora deal paying $132 million in stock for Whistler Medical Marijuana is …

Before digging into the topic at hand, it is important to make certain things clear. Call it a confession if you will. To begin, I don’t own any stocks that I am discussing today. Also, nobody is paying me to promote any stock or stock group. I enjoy the luxury of choice.

Equally important, I am a value-oriented investor. As opposed to a momentum investor that simply looks for what is hot at the moment, I look the same hot group and try to find good companies that have been overlooked.

Tovi from Potnetwork on Vimeo.

Smokin’ hot

Ask anyone close to cannabis and they will confirm that so far nothing could have made the start of 2019 any better than to have a boat full of cannabis stocks on New Year’s Day. Since then the NASDAQ has gained 7.7 percent and the S&P 500 7.5 percent. The HMMJ Index, however, has gained nearly 30 percent. The performance of the stock market, in general, has been punctuated by extreme volatility while cannabis stocks have been pretty much smokin’ hot and straight up.

[Green Growth’s hostile bid for Aphria is official. The consequences could be devastating for shareholders.]

Of course, this raises the question: is it possible that the cannabis stock price momentum will continue? Based purely on probabilities, the answer is no.

But considering the positive momentum in legalization, the accelerating pace of consolidation and the huge prices being paid for deals, there is a very good chance that cannabis stocks will be one of the best places to be this year.

Searching for value

In a deal driven environment financed largely with equity, companies whose stocks lag the performance of their peers are vulnerable to take over. Most deals thus far in the cannabis industry have been very friendly. But that cannot rule out hostile takeovers either.

The point here is that cannabis stocks, in general, are priced on their long term potential, not current profits. On this basis, it can be argued that virtually all cannabis stocks are overvalued. For our purposes, it doesn’t matter either way: the key is the value differential. This is what makes lagging cannabis stocks so interesting.

MedMen Enterprises Inc.

There are several reasons for MedMen (MMNFF) standing out. So far this month the stock has gained just 13.3 percent. That is good enough to beat the market but less than the performance of its peers. So a big price differential exists. During last years spike, the shares sold for over $7.00, twice the current price.

MedMen’s current market value at $1.4 billion represents a digestible size for the industries big guys like Tilray (NASDAQ:TLRY) at $6.7 billion, Canopy Growth (NYSE:CGC) at $15 billion, or Aurora Cannabis (NYSE:ACB) at $6.23 billion. The recently announced Aurora deal paying $132 million in stock for Whistler Medical Marijuana is a perfect example of effective use of overpriced equity.

FYI this translates to over $26.40 per gram of Whistler’s 5000 kilograms of production. Clearly, Aurora is paying dearly for the Whistler brand.

[Why the Cronos and Altria partnership is the cannabis deal of the decade]

The Tilray deal with Authentic Brands was far more reasonable. Nevertheless, it only served to underscore the importance of the recreational cannabis market and the value of brand names. As a former Wall Street consumer products analyst, I am in awe of the power of brand names like Coca Cola, Levi’s, Apple, and Amazon.

This is where MedMen fits into my bias. Somehow the brand name resonates. Even though the brand is unknown in the vast majority of the world, somehow it touches all of the points that spell solid, healthy and hip providers of medical and recreational cannabis. Headquartered in the cannabis legal Culver City, CA, MedMen covers the vertical from cultivation, production, and retail distribution.

MedMen’s business is growing very nicely through 69 retail outlets in 12 states. Last June the company opened a store on trendy Abbot Kinney Blvd in Venice, CA. This is a showcase location, where the rents are so high that it is debatable if any retailer on the street earns much. It is a good example of solid brand building.

Fast growth means burning cash

In the first quarter of FY 2019, revenues grew tenfold to just over $20 million. Second quarter results are due any day. The average forecast is for a further doubling to $40 million reaching nearly $190 for all of 2019.

The company is sitting on $64 million of unrestricted cash. So you can’t ask for much more. But every company has their weak points and MedMen has several.

As of the first quarter balance sheet, there were $60 million in notes payables due in coming months. So all that cash is spoken for. Next is MedMen’s spectacular growth comes at a price. In the first quarter operations lost $63 million. This is not an indictment of management or its business model. Most young rapidly growing companies are no different.

[Canopy Growth Corporation continues to dominate the global cannabis market with expansion into the UK and Poland]

But growth requires capital, and in the case of cannabis, MedMen’s style of vertical integration and brand building takes a bundle. None of this is to suggest that we have knowledge of deal talks, simply to point out value differentials. Oh yes, there is one other thing to keep in mind. There are only two Wall Street analyst publishing on the company so caution is advised. These two bulls have a one-year price target just about double the current $3.06 level.

Now that could offer some value.

Related Posts:

  • No Related Posts

Buds & Duds: Canopy Growth falls as CEO warns of bubble for cannabis industry

Canopy Growth Corp (NYSE:CGC) (TSE:WEED) dropped 1.3% to US$43.10 in New York trading after CEO Bruce Linton told CNBC at the World …

Cannabis stocks in the US and Canada had a down day Wednesday, trading in the same direction as the S&P/TSX Composite Index.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, dropped 0.4% to 259.86.

Duds:

Canopy Growth Corp (NYSE:CGC) (TSE:WEED) dropped 0.5% to US$43.45 in New York trading after CEO Bruce Linton told CNBC at the World Economic Forum in Davos, Switzerland, that the cannabis industry faces a “massive inflationary bubble” and that investors should be careful.

“Everybody wants to be in the cannabis space, and I think investors have to be selective because … there will be a new name every week,” Linton said.

READ: Canada’s Canopy Growth shares bloom as it receives license to develop industrial hemp in New York

Merger speculation sank Aphria Inc (NYSE:APHA) (TSE:APHA). Its stock fell 2.3% to US$6.92 in New York on Wednesday after advising shareholders to take no action until its board has made a recommendation regarding an unsolicited takeover offer from Green Growth Brands Inc. (OTCMKTS:GGBXF) (CSE:GGB).

The agreement could value the Canadian cannabis company at C$2.35 billion (US$1.76 billion).

In December, Aphria rejected Green Growth’s takeover bid on the grounds that it significantly undervalued the company.

Aphria fell 2.1% to C$9.23 in Canadian trading. Green Growth declined 2.3% to US$4.37 on the OTC Markets and was down 2.8% to C$5.81 in Canada.

Hexo Corp (TSE:HEXO) slipped 2.1% to C$6.92 in Toronto after earlier this week announcing a proposed offering of common shares of C$50 million (US$37 million).

In September, Riposte Capital, which owned 2.5% of the cannabis company, urged it to explore more deals.

Buds:

The Green Organic Dutchman Holdings (TSE:TGOD) (OTCQX:TGODF) shares climbed, up 2.7% at C$3.05.

Last week, the company announced it had tapped Dr Rav Kumar as its chief scientific officer.

Organigram Holdings Inc (OTCMKTS:OGRMF) (CVE:OGI) shares were up 0.2% to US$4.69 in OTC Markets trading after the licensed cannabis producer announced OrganiCare, a program designed to improve access to medical cannabis for low-income patients.

Effective immediately, patients who earn an annual income less than C$35,000 per year qualify for a 30% price reduction on dried cannabis products and oils, the New Brunswick company said.

The stock advanced 1.6% to C$6.26 in Canadian trading.

Contact Dennis Fitzgerald at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here

Related Posts:

  • No Related Posts

Cannabis Market Analysis Report: Canopy Growth Corporation Aurora Cannabis Inc., Medmen …

Cannabis Market Analysis Report: Canopy Growth Corporation Aurora Cannabis Inc., Medmen, Terra Tech Corp., Aphria Inc, Vivo Cannabis Inc., …

Cannabis market is expected to rise from its initial estimated value of USD 13.4 million in 2018 to an estimated value of USD 110.7 million by 2026, registering a CAGR of 32.2% during the forecast period of 2019-2026. This rise in market value can be attributed to rising need of plant protein amid rising amount of health concerns and veganism worldwide.

The cannabis industry is composed of legal cultivators and producers, consumers, independent industrial standards bodies, ancillary products and services, regulators and researchers concerning cannabis and its industrial derivative, hemp. The cannabis industry has been inhibited by regulatory restrictions for most of recent history, but the legal market has emerged rapidly as more governments legalize medical and adult use. Uruguay became the first country to legalize recreational marijuana through legislation in December, 2013 Cannabis in Uruguay. Canada became the first country to legalize private sales of recreational marijuana with Bill C-45 in 2018 Cannabis in Canada. Recently, Coca-Cola has shown interest in producing cannabis infused drinks.

Legal marijuana has started gaining traction worldwide due to very high demand among consumers and increasing legalization of recreational or medical marijuana in various countries. Additionally, high public and private investment for research and the development of safer forms of ingesting marijuana such as tinctures, oils, vapes and other edibles are expected to positively reinforce market growth. The number of conditions treated using medical marijuana is growing rapidly, as new patients are added to the market, the demand for medical marijuana is expected to increase multiple folds over the forecast period. Countries like Canada and the U.S. are moving towards legalization of marijuana for recreational purposes, this in turn is expected to create a shift form medical to recreational marijuana. Lengthy purchase and approval process for medical marijuana prescription and ease of availability of recreational marijuana is expected to trigger this this change.

Get Exclusive Sample PDF of Report at: databridgemarketresearch.com/request-a-sample/?dbmr=globa…

Global cannabis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cannabis market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Competitors:

Canopy Growth Corporation Aurora Cannabis Inc., Medmen, Terra Tech Corp., Aphria Inc., Vivo Cannabis Inc., Chronos Group Inc., Medical Marijuana, Inc., Stenocare, Tikun Olam, Organigrams Holding Inc., Cannabis Science Inc., Maricann Group Inc., Tilray Inc, Hexo, Scotts Miracle-Gro Co., GW Pharmaceuticals PLC,, MedReLeaf Corp., Insys Therapeutics Inc., CanniMed Therapeutics Inc., Cara Therapeutics Inc

Market Drivers:

• Growing medicinal application of cannabis

• Increasing legalization of cannabis

Market Restraints:

• Complex regulatory structure for the usage of cannabis

Know More Business Opportunities In Cannabis Market. Speak To Our Analyst And Gain Crucial Industry Insights That Will Help Your Business Expand. Request Analyst Call for More Insight databridgemarketresearch.com/speak-to-analyst/?dbmr=globa…

Cannabis Market Segmentation:

• By Product Type

o Flower

o Concentrates

o Others

• By Application

o Medical

o Recreational

• By Compound

o Tetrahydrocannabinol (THC)-Dominant

o Cannabidiol (CBD)-Dominant

o Balanced THC & CBD

• By Geography

o North America

 U.S.

 Canada

 Mexico

o South America

 Brazil

 Argentina

 Rest of South America

o Europe

 Germany

 France

 United Kingdom

 Italy

 Spain

 Russia

…And More GET DETAILED TOC AT databridgemarketresearch.com/toc/?dbmr=global-cannabis-ma…

Data Bridge Market Research set forth itself as an unconventional and esoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Related Posts:

  • No Related Posts

Canadians spent $54M on cannabis in first month after legalization

… $10 billion a year created a boom in the value of producers such as Canopy Growth Corp. and Aurora Cannabis Inc. Canada became the first Group …

Canadians bought $54 million of marijuana from stores in the first full month after sales were legalized, some of the clearest evidence yet of the market’s potential.

Statistics Canada’s figure for November released Wednesday follows an earlier estimate that sales were $43 million in the first two weeks following legalization on Oct. 17. The Ottawa- based agency added cannabis to standard monthly reports on retail sales as part of wider effort to update the nation’s economic accounts.

“Retail figures will vary as new stores continue to come on line and the marketplace continues to evolve,” the agency’s report said.

The potential for a market worth between $5.5 billion and $10 billion a year created a boom in the value of producers such as Canopy Growth Corp. and Aurora Cannabis Inc. Canada became the first Group of Seven nation to legalize the drug as Prime Minister Justin Trudeau said prohibition was a failed system that gave profits to criminal gangs and allowed rampant youth consumption.

Statistics Canada’s numbers may understate things because sales in Ontario, the most populous province, are limited to online orders until a batch of 25 stores opens in April. Stores in other provinces also ran out of some products and consumer choices are being limited because edibles remain forbidden.

“We’re in a supply constrained environment, so all of this is a little premature because the demand is clearly outstripping supply,’’ Trevor Fencott, Chief Executive Officer of Fire & Flower Inc., said by phone before the report. The company says it has made $10 million in sales and expanded to nine locations in Alberta and Saskatchewan from five since the market opened.

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new – and controversial – Canadian recreational marijuana industry. Read more from the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.

Related Posts:

  • No Related Posts